HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral contraceptive containing desogestrel in the maintenance of the remission of hirsutism: monthly versus bimonthly treatment.

Abstract
A treatment to keep hirsutism in remission while minimizing lipid disturbances was attempted in 20 formerly hirsute patients with hirsutism scores already greatly reduced after oral contraceptives (OCs) treatment. After OCs discontinuation for one to three months, they were thereafter treated for two years as follows: 9 patients received ethinyl estradiol (30 micrograms/day) plus desogestrel (150 micrograms/day) in three-week cycles every month (monthly); 6 patients received the same formulation during three-week cycles every other month (bimonthly); 5 patients received no treatment. In the untreated patients, abnormal hirsutism scores reappeared within 12-18 months; the levels of testosterone and free testosterone, initially high following discontinuation of OCs, remained elevated. Monthly treatment kept hirsutism in remission, and testosterone and free testosterone levels decreased. Bimonthly treatment was equally effective keeping hirsutism in remission, although testosterone levels did not decrease. Bimonthly treatment was not better than monthly treatment in relation to changes in plasma lipids (cholesterol, HDL-cholesterol, triglycerides).
AuthorsA Porcile, E Gallardo
JournalContraception (Contraception) Vol. 44 Issue 5 Pg. 533-40 (Nov 1991) ISSN: 0010-7824 [Print] United States
PMID1839144 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Contraceptives, Oral
  • Norpregnenes
  • Progesterone Congeners
  • Triglycerides
  • Testosterone
  • Desogestrel
  • Cholesterol
Topics
  • Analysis of Variance
  • Cholesterol (blood)
  • Contraceptives, Oral (pharmacology, therapeutic use)
  • Desogestrel
  • Drug Administration Schedule
  • Female
  • Hirsutism (prevention & control)
  • Humans
  • Norpregnenes (pharmacology, therapeutic use)
  • Progesterone Congeners (therapeutic use)
  • Testosterone (blood)
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: